Wed.May 14, 2025

article thumbnail

Adult-Onset Type 1 Diabetes Increases Risk of Cardiovascular Disease

Drug Topics

Investigators also find that patients diagnosed with type 1 diabetes later in life do not have a better prognosis compared to those diagnosed earlier.

380
380
article thumbnail

FDA Approves Belzutifan for Treatment of Locally Advanced, Unresectable, or Metastatic Pheochromocytoma and Paraganglioma

Pharmacy Times

The FDA approves belzutifan, the first oral treatment for pheochromocytoma and paraganglioma, offering a new treatment pathway for patients with these rare tumors.

FDA 127
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: In combative hearings, Kennedy defends HHS cuts, backtracks — and lashes out

STAT

WASHINGTON — In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending sweeping changes at his agency and backtracking on aspects of a reorganization he nevertheless said would be “painful.” He repeatedly cast doubts on reports about negative impacts of the changes, often calling them a “canard.

114
114
article thumbnail

FDA Grants Accelerated Approval to Telisotuzumab vedotin-tllv for NSCLC

Pharmacy Times

Emrelis is a groundbreaking treatment for advanced non-small cell lung cancer, targeting high c-Met protein overexpression.

FDA 120
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

UnitedHealth CEO Chris Witty steps down

pharmaphorum

Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025

78
article thumbnail

CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy

Pharmacy Times

The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.

82

More Trending

article thumbnail

Children With Sickle Cell Disease Have Higher Rates of Invasive Pneumococcal Disease Despite Vaccination

Pharmacy Times

Like other high-risk groups, children with sickle cell disease have a heightened risk of invasive pneumococcal disease, even if they receive proper pneumococcal conjugate vaccine coverage.

article thumbnail

Novo Nordisk’s Sogroya Demonstrates Efficacy in Children with Growth Disorders

PharmExec

Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.

52
article thumbnail

Icotrokinra Demonstrates Significant Skin Clearance in Difficult-to-Treat Scalp, Genital Psoriasis

Pharmacy Times

New trial results reveal icotrokinra's effectiveness in achieving significant skin clearance for challenging scalp and genital psoriasis.

73
article thumbnail

GSK to spend $2bn on Phase III liver disease drug acquisition

Pharmaceutical Technology

The deal comes at a time of revival into liver disease treatment investment as market opportunity beckons.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New OTC Option Offers Patients Itch Relief During Summer Activities

Pharmacy Times

The seasonal surge in skin irritations underscores the ongoing need for effective and convenient remedies.

73
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

From Gen Z to Millennials to seniors, each age group has unique access challenges and care preferences when it comes to mental health treatment, the survey found.

51
article thumbnail

Engaging in Research and Disseminating Information Are Essential For All Stakeholders, Experts Say

Pharmacy Times

Effectively communicating research findings to patients, health care professionals, and policy payers is necessary for engagement.

article thumbnail

Recipharm and PLG to support pharma companies in expediting market approval

Pharmaceutical Technology

Recipharm has joined forces with ProductLife Group (PLG) to support (bio)pharmaceutical firms in expediting market approval and trial time.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Agile, Microlearning and Engaging Training for Clinical Trial Sites: A Strategic Approach to knowledge and learning management for Biotech Sponsors

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

UnitedHealth Group revealed additional details about the compensation package for CEO Stephen Hemsley in a filing with the Securities and Exchange Commission.

article thumbnail

Star Jones Leads Heart Health Awareness Campaign for Medtronic

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

FDA Begins Granting Advanced Manufacturing Technology Designations

The FDA Law Blog

By Mark A. Tobolowsky & Mark I. Schwartz In early April, Cellares became the first company to announce receipt of an Advanced Manufacturing Technology (AMT) designation from FDA. The designation was granted by CBER to Cellares for its automated cell therapy platform, the Cell Shuttle. We were excited to see the news and look forward to seeing the full implementation of the AMT program and its potential benefits.

FDA 59
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Basics in Programmatic Display Ads

Pharma Marketing Network

In todays digital-first healthcare landscape, programmatic display ads have become a cornerstone of pharmaceutical marketing strategies. By leveraging automated, data-driven ad placements, pharma brands can reach healthcare professionals (HCPs) and patients with unprecedented precision and efficiency. This guide delves into the essentials of programmatic advertising, its benefits, and best practices for pharma marketers.

HIPAA 52
article thumbnail

Multilateral benefit sharing mechanism for digital sequence information

pharmaphorum

Since December 2022, and COP decision 15/9, members of the Convention on Biological Diversity (the CBD) have been negotiating a multilateral mechanism for the fair and equitable sharing of benefits arising from the use of Digital Sequence Information (DSI) on genetic resources.

52
article thumbnail

Drug overdose deaths fell sharply in 2024, as fentanyl cases dropped but meth spiked

STAT

Drug deaths plummeted in 2024, according to new federal data.  An estimated 80,391 people died of a drug overdose in the U.S. last year, marking the lowest total since 2019. The sum represents a roughly 27% decrease from 2023, according to the Centers for Disease Control and Prevention.

125
125
article thumbnail

von der Leyen loses bid to stop disclosure of Pfizer texts

pharmaphorum

Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with Pfizer's CEO on COVID-19 vaccine procurement

article thumbnail

CGMs Can Reduce Nocturnal, Daytime Hypoglycemia for Patients With Type 1 Diabetes

Drug Topics

Investigators also found that nocturnal hypoglycemia is a strong predictor of daytime hypoglycemia.

315
315
article thumbnail

WHO trims top management ranks amid financial crunch

STAT

The World Health Organization, which faces an extraordinary financial crunch in the wake of the U.S. withdrawal from the agency, has dramatically trimmed its top management.  Gone from the leadership is Mike Ryan , who has led the Health Emergencies Program since 2019 and who has been with the WHO, off and on, for decades. Recently Ryan has also been serving as the WHO’s executive director.

144
144
article thumbnail

Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions

Drug Topics

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

281
281
article thumbnail

Former FDA head Robert Califf says RFK Jr.’s vaccine rhetoric is ‘doing harm’ to Americans

STAT

SAN FRANCISCO — Former Food and Drug Administration Commissioner Robert Califf said health secretary Robert F. Kennedy Jr.’s hesitance to endorse vaccines is harming the American public.  “Fundamental vaccination saves millions of lives every year already, and he’s busy eroding public confidence in it,” Califf said at STAT’s Breakthrough Summit West conference on Wednesday.

Vaccines 135
article thumbnail

How NCPDP Uses Innovation to Help Pharmacists Be More Effective | NCPDP 2025

Drug Topics

Rick Sage, Executive Vice President of Innovation & Standards at NCPDP, discusses his role and how his team is using innovation to support the pharmacy profession.

281
281
article thumbnail

Women’s health faces growing headwinds, despite jump in venture investment

PharmaVoice

While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, one biotech CEO said.

130
130
article thumbnail

Pharmacists’ Role in Remote Patient Care Dependent on Data Infrastructure | NCPDP 2025

Drug Topics

In part 3 of our interview with Vin Gupta, MD, he discusses pharmacists role in remote patient care amid a growing technological infrastructure.

article thumbnail

First patient treated with prime editing

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. We’ve got a lot going on today. A bunch of my colleagues are in San Francisco for our Breakthrough Summit West , which is focused on the impact of AI on health innovation. Among those taking the stage: Robert Califf and Reed Jobs.

108
108
article thumbnail

How Interoperability, Data Infrastructure Create New Opportunities for Pharmacies | NCPDP 2025

Drug Topics

Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.

247
247
article thumbnail

‘I don’t know that’: Federal judge flags factual claims in NIH grant termination case

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning & happy Summit day!

104
104
article thumbnail

Case Studies and Value Demonstration in Pharmacy-Based Point-of-Care Testing

Drug Topics

A panelist discusses how implementing point-of-care testing can help create a formal structure for pharmacists to be recognized as providers who can help reduce health care costs by offering accessible care options.

247
247